IGF1R and neoplasm: However, the possibility that the frequency was underestimated still remains, because low percentage of MRAS mutation alleles or low copy‐number gain of IGF1R in the tumor tissues of Type IV with low tumor cell contents could not be detected by Sanger sequencing or qPCR, respectively.